| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.06.21 | Basilea Pharmaceutica - Multiple catalysts on the horizon | 417 | Edison Investment Research | Basilea has provided an update on the three ongoing derazantinib Phase II trials (FIDES-01/02/03) that will define its utility in iCCA (bile duct cancer), urothelial cancer (UC) and gastric cancer (GC).... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.263 |
| SUPER MICRO COMPUTER | 1.627 |
| BAYER | 1.394 |
| BYD | 1.169 |
| AMAZON | 1.149 |
| NVIDIA | 1.095 |
| DEUTSCHE BANK | 998 |
| TESLA | 933 |
| NEL | 917 |
| TUI | 891 |
| PFIZER | 815 |
| MERCEDES-BENZ | 679 |
| CANOPY GROWTH | 643 |
| AMD | 636 |
| PAYPAL | 589 |
| VOLKSWAGEN | 575 |
| COMMERZBANK | 570 |
| STARBUCKS | 566 |
| NOVO NORDISK | 535 |
| BARRICK GOLD | 503 |
| PLUG POWER | 492 |
| AIXTRON SE | 475 |
| AURORA CANNABIS | 445 |
| RHEINMETALL | 437 |
| RWE | 425 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
